Holen Sie sich die Stockscreener-App
1.23
1.34%
-0.01
Schlusskurs vom Vortag:
$1.24
Offen:
$1.25
24-Stunden-Volumen:
46,524
Relative Volume:
0.02
Marktkapitalisierung:
$3.44M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-8.85M
KGV:
-0.0756
EPS:
-16.2673
Netto-Cashflow:
$-9.34M
1W Leistung:
-2.13%
1M Leistung:
-5.17%
6M Leistung:
-77.37%
1J Leistung:
-89.63%
1-Tages-Spanne:
$1.208
$1.26
1-Wochen-Bereich:
$1.208
$1.35
52-Wochen-Spanne:
$1.11
$23.70
Dermata Therapeutics Inc Stock (DRMA) Company Profile
Firmenname
Dermata Therapeutics Inc
Sektor
Branche
Telefon
(858)-223-0882
Adresse
3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO
Compare DRMA vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DRMA
Dermata Therapeutics Inc
|
1.215 | 3.52M | 0 | -8.85M | -9.34M | -16.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
471.84 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.46 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
696.45 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.22 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Dermata Therapeutics Inc Aktie (DRMA) Neueste Nachrichten
Dermata Therapeutics names Kyra Peckaitis VP of marketing By Investing.com - Investing.com Canada
Dermata Therapeutics names Kyra Peckaitis VP of marketing - Investing.com Nigeria
Dermata Announces Appointment of Kyra Peckaitis as Vice President, Marketing - Nasdaq
Retail Surge: Is Dermata Therapeutics Inc Equity Warrant a strong candidate for buy and holdJuly 2025 Short Interest & Accurate Intraday Trading Signals - baoquankhu1.vn
Exit Recap: Is Dermata Therapeutics Inc a momentum stockMarket Volume Report & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Dermata Therapeutics Launches Tome Skincare Line to Address Daily Skin Health Needs - geneonline.com
Dermata Opens a New Chapter with the Release of Tome Skincare - standard-journal.com
Once‑weekly acne treatment at home: Dermata’s new Tome skincare line - Stock Titan
DRMA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Wall Street Zen Upgrades Dermata Therapeutics (NASDAQ:DRMA) to Hold - Defense World
Dermata Therapeutics Announces Board Resignation and Size Reduction - TipRanks
Board shakeup at Dermata (DRMA) as director Mary Fisher plans exit - Stock Titan
ARMISTICE CAPITAL, LLC Reduces Stake in Dermata Therapeutics Inc - GuruFocus
Update Report: Will Dermata Therapeutics Inc benefit from seasonalityPortfolio Performance Report & Weekly Return Optimization Alerts - baoquankhu1.vn
DRMAW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Large Dermata (DRMA) holder Gerald Proehl reports 17.3% ownership stake - Stock Titan
Growth Value: What is Dermata Therapeutics Incs valuation compared to sector2025 Winners & Losers & Technical Pattern Alert System - baoquankhu1.vn
Contrasting Qiagen (NYSE:QGEN) & Dermata Therapeutics (NASDAQ:DRMA) - Defense World
Chipmakers Recap: Can Dermata Therapeutics Inc Equity Warrant grow without external fundingJuly 2025 Rallies & Daily Risk Controlled Trade Plans - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Growth Recap: Is Dermata Therapeutics Inc Equity Warrant benefiting from innovation trendsQuarterly Growth Report & Low Drawdown Trading Techniques - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Market Movers | Winners: ADVB, KNRX, DRMA | Losers: MBRX, ALIT, DBGI - Trefis
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Armistice Capital, Steven Boyd disclose 4.99% stake in Dermata (DRMA) - Stock Titan
ACXP PE Ratio & Valuation, Is ACXP Overvalued - Intellectia AI
Can Dermata Therapeutics Inc. expand into new markets2025 AllTime Highs & Verified Technical Trade Signals - mfd.ru
Can Dermata Therapeutics Inc. Equity Warrant stock double in the next yearWeekly Market Summary & AI Powered Market Trend Analysis - mfd.ru
How rising interest rates impact Dermata Therapeutics Inc. stockJuly 2025 Chart Watch & Verified Stock Trade Ideas - mfd.ru
HSDT PE Ratio & Valuation, Is HSDT Overvalued - Intellectia AI
DRMA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Bristol Investment Fund Ltd. v. Dermata Therapeutics Inc.: Complaint (‘$160K Breach of Contract’) - OffshoreAlert
Bull Run: Can AVITA Medical Inc weather a recessionMarket Performance Summary & Precise Buy Zone Identification - baoquankhu1.vn
Will Dermata Therapeutics Inc. stock benefit from AI adoption2025 Momentum Check & AI Forecasted Entry/Exit Points - mfd.ru
Stock Report: Should I average down on Dermata Therapeutics Inc Equity Warrant stockJuly 2025 Short Interest & Real-Time Buy Signal Notifications - baoquankhu1.vn
Surprises Report: What are Twin Hospitality Group Incs technical support levels - baoquankhu1.vn
Is Dermata Therapeutics Inc a momentum stockTrade Volume Report & Long-Term Investment Growth Plans - baoquankhu1.vn
Aug Opening: What are the future prospects of iSpecimen Inc2025 Sector Review & Verified Momentum Stock Alerts - baoquankhu1.vn
Aug Weekly: Is Eureka Acquisition Corp Debt Equity Composite Units a cyclical or defensive stockGold Moves & Fast Moving Trade Plans - baoquankhu1.vn
Will Dermata Therapeutics Inc. Equity Warrant stock outperform Nasdaq indexJuly 2025 Update & Entry Point Confirmation Signals - mfd.ru
Loss Report: Is Dermata Therapeutics Inc Equity Warrant stock risky to hold nowWeekly Gains Summary & Verified Entry Point Detection - baoquankhu1.vn
History Review: Can ALUR disrupt its industryJuly 2025 Macro Moves & Growth Focused Stock Reports - baoquankhu1.vn
What is Dermata Therapeutics Inc.’s valuation compared to sectorJuly 2025 Spike Watch & Target Return Focused Picks - mfd.ru
Tuesday's after hours session: top gainers and losers - Chartmill
Meme Stocks: Is NRx Pharmaceuticals Inc Equity Warrant forming a breakout pattern2025 Market Overview & Expert Curated Trade Setups - baoquankhu1.vn
Dermata Therapeutics increases at-the-market offering by $705,000 - Investing.com Nigeria
Dermata Therapeutics increases at-the-market offering by $705,000 By Investing.com - Investing.com South Africa
Dermata Therapeutics Expands At-The-Market Equity Offering Capacity - TipRanks
Market Movers | Winners: GRI, XXII, LRHC | Losers: NBY, EMAT, APUS - Trefis
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Gap Down: Why is AHLPRF stock going downMarket Activity Report & Accurate Intraday Trade Tips - baoquankhu1.vn
Finanzdaten der Dermata Therapeutics Inc-Aktie (DRMA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):